Skip to main content

Table 1 The plasma levels of lipids, lipoproteins, nitrite, vWF and rabbit's body weights in three groups of the study in three sampling sessions.

From: Early prevention by L-Arginine attenuates coronary atherosclerosis in a model of hypercholesterolemic animals; no positive results for treatment

Parameter/group

 

EP

LP

Control

Cholesterol

(mg/dl)

A

108.56 ± 20.1

94.13 ± 15.4

118.65 ± 12.1

 

I

1918.93 ± 245.4*

2291.68 ± 227.8*

138.38 ± 11.8 ‡

 

II

1275.00 ± 169.5* , †

1433.40 ± 161.3*, †

122.7 ± 10.5 ‡

Triglyceride (mg/dl)

A

122.61 ± 2.3

121.42 ± 3.9

119.31 ± 2.7

 

I

228.12 ± 26.7*

232.4 ± 25.6*

121.89 ± 4.3‡

 

II

147.0 ± 17.2†

141.02 ± 15.6†

117.90 ± 3.2‡

LDL

(mg/dl)

A

28.35 ± 9.4

44.01 ± 10.8

33.5 ± 8.9

 

I

1079.66 ± 118.2*

1418.99 ± 189.6*

42.76 ± 10.7 ‡

 

II

623.18 ± 126.5*, †

635.09 ± 113.7*, †

38.6 ± 11.4 ‡

HDL

(mg/dl)

A

15 ± 2.4

15.5 ± 1.3

16.4 ± 1.7

 

I

109.6 ± 20.1*

96.1 ± 11.6*

18.3 ± 1.4‡

 

II

60.6 ± 11.2*†

74.0 ± 9.4*†

20.0 ± 3.2‡

Nitrite

(μM/l)

A

11.40 ± 1.0

11.11 ± .8

9.86 ± .8

 

I

14.7 ± .5*, ‡

12.2 ± .7

9.86 ± .8

 

II

16.57 ± 1.2*, ‡

14.58 ± 2

8.83 ± .2

vWF

(IU/dl)

A

0.55 ± .06

0.42 ± .09

0.32 ± .04

 

I

0.49 ± .04

0.99 ± .1 *, ‡

0.35 ± .06

 

II

.08 ± .006*, †

.07 ± .006*, †

0.23 ± .04 ‡

Body weight

(kg)

A

2.15 ± 0.1

2.13 ± 0.2

1.87 ± 0.3

 

I

2.37 ± 0.2*

2.38 ± 0.1*

1.92 ± 0.2‡

 

II

2.51 ± 0.3†

2.45 ± 0.2†

2.0 ± 0.2‡

  1. A: pre-test sampling, I: after 4 weeks (phase I) and II: after 8 weeks (phase II).
  2. significant difference * from (A), † from (I); and ‡ from other groups (p < 0.05).